A bench scientist studying schistosomiasis must make a large commitment to maintain the parasite's life cycle, which necessarily involves a mammalian (definitive) host and the appropriate species of snail (intermediate host). This is often a difficult and expensive commitment to make, especially in the face of ever-tightening funds for tropical disease research. In addition to funding concerns, investigators usually face additional problems in the allocation of sufficient lab space to this effort (especially for snail rearing) and the limited availability of personnel experienced with life cycle upkeep. These problems can be especially daunting for the new investigator entering the field. Over 40 years ago, the National Institutes of Health–National Institute of Allergy and Infectious Diseases (NIH-NIAID) had the foresight to establish a resource from which investigators could obtain various schistosome life stages without having to expend the effort and funds necessary to maintain the entire life cycle on their own. This centralized resource translated into cost savings to both NIH-NIAID and to principal investigators by freeing up personnel costs on grants and allowing investigators to divert more funds to targeted research goals. Many investigators, especially those new to the field of tropical medicine, are only vaguely, if at all, aware of the scope of materials and support provided by this resource. This review is intended to help remedy that situation. Following a short history of the contract, we will give a brief description of the schistosome species provided, provide an estimate of the impact the resource has had on the research community, and describe some new additions and potential benefits the resource center might have for the ever-changing research interests of investigators.
References
[1]
Van Der Schalie H (1966) The role of snail intermediate hosts in culturing Schistosoma japonicum. Malacol 5: 17–20.
[2]
Bruce JI, Radke MG, Davis GM (1971) Culturing Biomphalaria and Oncomelania (Gastropoda) for large-scale studies of schistosomiasis. Biomed Report No. 19, 406th Med Lab 1–161.
[3]
Liang YS, Bruce JI, Boyd DA (1987) Laboratory cultivation of schistosome vector snails and maintenance of schistosome life cycles. Proc First Sino-Am Symp 1: 34–48.
[4]
Bruce JI, Liang YS (1992) Cultivation of schistosomes and snails for researchers in the United States of America and other countries. J Med & Appl Malacol 4: 13–30.
[5]
Newton WL (1955) The establishment of a strain of Australorbis glabratus which combines albinism and high susceptibility to infection with Schistosoma mansoni. J Parasitol 41: 526–528. doi: 10.2307/3273814
[6]
Fripp PJ (1965) Bilharziasis and bladder cancer. Brit J Cancer 19: 292–296. doi: 10.1038/bjc.1965.33
[7]
Hodder SL, Mahmoud AAF, Sorenson K, Weinert DM, Stein RL, et al. (2001) Predisposition to urinary tract epithelial metaplasia in Schistosoma haematobium infection. Am J Trop Med Hyg 63: 133–138.
[8]
James ER, Farrant J (1977) Recovery of infective Schistosoma mansoni schistosomula from liquid nitrogen: a step towards storage of a live schistosomiasis vaccine. Trans Roy Soc Trop Med Hyg 71: 498–500. doi: 10.1016/0035-9203(77)90143-2
[9]
Stirewalt M, Lewis FA, Cousin CE, Leef JL (1984) Cryopreservation of schistosomules of Schistosoma mansoni in quantity. Am J Trop Med Hyg 33: 116–124.
[10]
Brindley PJ, Lewis FA, McCutchan TF, Beuding E, Sher A (1989) A genomic change associated with the development of resistance to hycanthone in Schistosoma mansoni. Mol Biochem Parasitol 36: 243–252. doi: 10.1016/0166-6851(89)90172-2
[11]
Cooper LA, Lewis FA, File-Emperador S (1989) Re-establishing a life cycle of Schistosoma mansoni from cryopreserved larvae. J Parasitol 75: 353–356. doi: 10.2307/3282587
[12]
Hansen EL (1976) A cell line from embryos of Biomphalaria glabrata (Pulmonata): establishment and characteristics. In: Maramorosch M, editor. Invertebrate tissue culture. New York: Academic Press. pp. 75–99.
[13]
Wynn TA, Thompson RW, Cheever AW, Mentink-Kane MM (2004) Immunopathogenesis of schistosomiasis. Immunol Rev 201: 156–167. doi: 10.1111/j.0105-2896.2004.00176.x